CDK5 and cancer: Liu et al. demonstrated that, in glioblastoma, CDK5 could activate nuclear Akt to favour the cancer migration and invasion via the phosphorylation of isoform A of phosphatidylinositol 3-kinase enhancer (PIKE-A) [152].